Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor
about
Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal modelsAntiphospholipid antibodies: paradigm in transition.Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy.Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis.36-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature.Circulating Immune Complexes of IgA Bound to Beta 2 Glycoprotein are Strongly Associated with the Occurrence of Acute Thrombotic EventsBilateral adrenal hemorrhage in the background of Escherichia coli sepsis: a case report.Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule.β₂-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model.Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS.Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways.Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodiesNew therapeutic targets for the antiphospholipid syndrome.Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome.A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome.Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5.The prevalence of positive serum anticardiolipin antibodies and asymptomatic bacteriuria in women with recurrent abortions.Cross-talk between the complement and the kinin system in vascular permeability.Pathophysiology of the antiphospholipid antibody syndrome.Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation.Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss.Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome.LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA CarriersThe complement system at the embryo implantation site: friend or foe?Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studiesIdentification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis.Association of autoantibodies to heat-shock protein 60 with arterial vascular events in patients with antiphospholipid antibodies.Antiphospholipid-related chorea.Infectious origin of the antiphospholipid syndrome.Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases.Human β2-glycoprotein I attenuates mouse intestinal ischemia/reperfusion induced injury and inflammationIs there a microangiopathic antiphospholipid syndrome?Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium.Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome.New potential therapies for the treatment of antiphospholipid syndrome.European Forum on Antiphospholipid Antibodies: research in progress.C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies
P2860
Q30497721-E87E148F-87D7-458F-BB6F-85548DAF042FQ33293219-3FF39BC0-5B30-42BA-BED5-81083892A72EQ33382848-35DAF3AA-D79C-458A-A405-EE4A58EEAA00Q33401365-7ED7B62B-1340-46C9-A49D-6993545DFED4Q33406588-9654FD71-EA18-4EE8-9BF8-2B57109B2905Q33418663-701AD77D-54EE-4760-A450-B1C7905126EBQ33431396-0A2E4162-DCB6-4854-9A8E-880CD89C81EEQ33440226-C4FC49D0-5B8F-4DEA-9637-8F9A9B08D17EQ33741075-9BA53FC6-EF18-430A-A505-D7C89359C030Q33796355-55AC9F3C-34F8-4855-933A-1D15D51F685EQ33948737-DF6A4849-F22D-4E75-A3A6-DE2754475754Q33967600-FF73D0A0-F280-4C12-A166-A0302B8030A4Q34080920-0E669F73-45B8-4588-9C81-1D72EB87FBCFQ34140319-8FFB1DC2-033E-4D6E-BECC-45089242BAB2Q34287356-18242DAD-1D05-44D2-A9C2-3B89418D1392Q34364580-82926208-FFB8-43D9-B2FD-39C90596E90AQ34625994-868343B5-B623-4FC5-B6C3-8B876F050B35Q34667153-4FF7ACA3-B7D5-4772-948E-259F337C6939Q35182755-64844868-85C5-4610-9729-5B50FF2016C3Q35309024-BE120ADB-E3D7-4F79-8C95-E5F867E5402EQ35621012-3CFBB30C-6E81-4F0A-ACAE-F5A9E03D4A8DQ35818105-C758E6F0-D09F-4208-8497-8C9B90F73213Q35849691-60643084-0CD4-4008-B83C-EFC41E927DD9Q35854768-0C015919-6BE8-4EBA-800E-C7F7AAEF8F6FQ35874202-01E187D9-A20E-4516-8396-576BCC82A06DQ35907083-E417A313-D6F7-4143-9C2E-08F126CD530DQ35927443-46A6AB56-9BE2-44B7-99AA-62030E7C9EADQ36013878-871CEE79-E71A-4F9A-8D0E-D7618378C4FDQ36087118-09CCA01E-4FCB-49D6-9386-2A42F5A06CF2Q36300623-17380CF2-6DD0-4BF6-A89E-7D224B124C96Q36337350-B5CCA1EE-F05A-4BBF-8274-4748F147B8E3Q36339540-80A53E88-F7F8-4DF9-8B0D-4E0E266BE45DQ36573005-C80AF8BB-BF1E-4C16-93EE-468D76E66515Q36590359-BC933F7B-2CF1-4258-94DB-868A4C988999Q36759849-DAD97081-EE51-4874-8F22-9D7DE76BCCD1Q37077537-C8A5664F-67B8-4807-9269-AE4FB2A26D26Q37283036-0F6081F5-55F3-46CC-A294-493BB66FE615Q37481227-8EFA3E95-8842-49FB-B8CC-78745B0C7FE6Q37578126-5A0306BF-0A5D-4201-AD93-5C54ACD1927BQ37581827-09135DF2-36D1-4F98-97C1-C8885EE2D834
P2860
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor
description
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im Oktober 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/10/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/10/01)
@nl
наукова стаття, опублікована в жовтні 2005
@uk
مقالة علمية (نشرت في أكتوبر 2005)
@ar
name
Thrombus formation induced by ...... and requires a priming factor
@ast
Thrombus formation induced by ...... and requires a priming factor
@en
Thrombus formation induced by ...... and requires a priming factor
@nl
type
label
Thrombus formation induced by ...... and requires a priming factor
@ast
Thrombus formation induced by ...... and requires a priming factor
@en
Thrombus formation induced by ...... and requires a priming factor
@nl
prefLabel
Thrombus formation induced by ...... and requires a priming factor
@ast
Thrombus formation induced by ...... and requires a priming factor
@en
Thrombus formation induced by ...... and requires a priming factor
@nl
P2093
P3181
P1433
P1476
Thrombus formation induced by ...... and requires a priming factor
@en
P2093
Alessandra Debeus
Daniele Sblattero
Fabio Fischetti
Federica Ziller
Fleur Bossi
Francesco Tedesco
Paolo Durigutto
Paolo Macor
Roberta Bulla
Valentina Pellis
P304
P3181
P356
10.1182/BLOOD-2005-03-1319
P407
P577
2005-10-01T00:00:00Z